). E. faecium strain 4 is highly susceptible to PLA 2 (LD 50 ∼50 ng/ml), whereas E. faecium strain 6 is less susceptible to PLA 2 (LD 50 ∼500 ng/ml).
Introduction
Multicellular organisms developed multiple defense mechanisms to deal with invasion and infection by microorganisms. The inflammatory reaction elicited by the invasion of bacteria mobilizes both cellular (1) (2) (3) (4) and extracellular (5) antimicrobial factors. Using a rabbit model of sterile inflammation, we have shown that proteins secreted by the cells in the exudate or entering from the circulation accumulate in the ascitic fluid and exert potent bactericidal activity against both Grampositive (6) and Gram-negative bacteria (5) , as well as fungi (Weinrauch, Y., and Foreman-Wykert, A.K., unpublished observations). A 14-kDa, secretory group IIA PLA 2 present in concentrations ranging from 100 to 1,000 ng/ml is largely responsible for the potent bactericidal activity of these inflammatory fluids against many Gram-positive bacteria (ref. 6 ; and Liang, N.S., et al., manuscript in preparation).
For this PLA 2 to exert its bactericidal effects, the enzyme must first bind to the bacteria and then traverse the multiple peptidoglycan layers of the cell wall to reach and hydrolyze the phospholipids in the cell membrane. The thick peptidoglycan layer of Gram-positive bacteria can be highly cross-linked (7) and may constitute a barrier to PLA 2 access of the cell membrane. In line with this supposition, protoplasts of Staphylococcus aureus and Bacillus subtilis are more susceptible to PLA 2 than intact bacteria (Liang, N.S., et al., manuscript in preparation). However, the potency of mammalian group IIA PLA 2 (LD 90 1-10 nM) (6) against S. aureus that contain highly cross-linked cell-wall peptidoglycans (7) implies that, even in these organisms, regions may exist that permit enzyme penetration to the cell membrane. In this study, we have examined the effect of cell growth, bacterial autolysins, and cell-wall active antibiotics on the phospholipolytic and bactericidal activity of PLA 2 . Our findings suggest that bacterial envelope sites engaged in the normal cell-wall turnover associated with cell growth, division, and separation are the sites at which PLA 2 preferentially acts against Gram-positive bacteria.
We have shown previously that a group IIA phospholipase A 2 (PLA 2 ) is responsible for the potent bactericidal activity of inflammatory fluids against many Gram-positive bacteria. To exert its antibacterial activity, this PLA 2 must first bind and traverse the bacterial cell wall to produce the extensive degradation of membrane phospholipids (PL) required for bacterial killing. In this study, we have examined the properties of the cell-wall that may determine the potency of group IIA PLA 2 action. Inhibition of bacterial growth by nutrient deprivation or a bacteriostatic antibiotic reversibly increased bacterial resistance to PLA 2 -triggered PL degradation and killing. Conversely, pretreatment of Staphylococcus aureus or Enterococcus faecium with subinhibitory doses of β-lactam antibiotics increased the rate and extent of PL degradation and/or bacterial killing after addition of PLA 2 . Isogenic wild-type (lyt + ) and autolysis-deficient (lyt -) strains of S. aureus were equally sensitive to the phospholipolytic action of PLA 2 , but killing and lysis was much greater in the lyt + strain. Thus, changes in cell-wall cross-linking and/or autolytic activity can modulate PLA 2 action either by affecting enzyme access to membrane PL or by the coupling of massive PL degradation to autolysin-dependent killing and bacterial lysis or both. Taken together, these findings suggest that the bacterial envelope sites engaged in cell growth may represent preferential sites for the action and cytotoxic consequences of group IIA PLA 2 attack against Gram-positive bacteria.
J. Clin. Invest. 103:715-721 (1999) concentration of 1.5 × 10 7 bacteria/ml. The E. faecium strains were grown overnight (>16 h) in Brain Heart Infusion Broth (Difco Laboratories) supplemented with 0.5% (vol/vol) heatinactivated horse serum (GIBCO BRL, Gaithersburg, Maryland, USA). After harvesting, the bacteria were sedimented by centrifugation at 3,000 g for 5 min and resuspended in sterile physiological saline (Baxter Healthcare Corp., Deerfield, Illinois, USA) to a concentration of 10 9 bacteria/ml. The bacteria were used within 30 min of harvesting.
Collection of ascitic fluid, preparation of ascitic fluid filtrate, and purification of PLA 2 . Sterile inflammatory exudates were elicited in New Zealand white rabbits by intraperitoneal injection of 300 ml of sterile physiological saline (Baxter Healthcare Corp.) supplemented with oyster glycogen (2.5 mg/ml; United States Biochemical Corp., Cleveland, Ohio, USA). After 16 h, the inflammatory exudate was collected, and the ascitic fluid (AF) was prepared as described previously (5, 6) . Protein-poor (<1% of AF protein concentration) AF filtrate was prepared by filtration of the cell-free inflammatory AF in a centrifugal concentrator (Centricon-10; Amicon, Danvers, Massachusetts, USA) (1600 g for 1 h) at 4°C (6) . The AF filtrate was sterile filtered (0.45 µm; Nalge Nunc International, Rochester, New York, USA) and stored at -20°C until used. Group IIA PLA 2 from rabbit AF was purified as described previously (6, 10, 11) .
Assay of PLA 2 catalytic activity. The catalytic activity of PLA 2 in various assay media was measured against autoclaved [1-14 C]oleate-labeled Escherichia coli as described previously (10) (11) (12) . Arbitrary units of PLA 2 activity were measured as described previously (6, 12) .
Recombinant human PLA 2 . Recombinant human group IIA PLA 2 was expressed in E. coli and purified as described previously (ref. 13 ; and Liang, N.S., et al., manuscript in preparation) .
Radiolabeling of S. aureus lipids during growth. To radiolabel the lipids of S. aureus, the bacteria were subcultured to mid-logarithmic phase in TSB supplemented with 1 µCi/ml of [1-14 C]oleic acid (40-60 mCi/mmol) (Du Pont NEN Research Products, Boston, Massachusetts, USA) and 0.1% BSA. Stationary phase cultures were grown overnight in TSB supplemented with 2 µCi/ml of [1-14 C]oleic acid and 0.1% BSA. Bacteria harvested at mid-logarithmic and stationary phases were incubated in medium without [1-14 C] oleic acid at 37°C for 20 min to chase incorporated, unesterified precursor fatty acid into ester positions and then were washed as described previously (6), except that stationary phase bacteria were washed in medium (TSB) derived from stationary phase cultures (used TSB). The composition of lipids in bacteria harvested at midlogarithmic or stationary phase was determined by extraction in CHCl 3 /CH 3 OH (14) and analysis by TLC of radiolabeled material recovered in the CHCl 3 phase (>95% of total) (6). In both mid-logarithmic and stationary phase bacteria, ∼70% of radiolabeled material was phospholipid, nearly all of which was phosphatidyl glycerol.
Assay of bacterial phospholipid degradation. Because phospholipid breakdown products formed during PLA 2 treatment are quantitatively recovered in the extracellular medium complexed to albumin, whereas undigested phospholipid remains within the bacterial envelope, phospholipid degradation was routinely measured as accumulation of radioactive material in the supernatant recovered after sedimentation of the bacteria (11,000 g for 4 min). To confirm that release corresponded quantitatively to phospholipid degradation, the lipids of S. aureus, with and without PLA 2 treatment, were extracted using the method of Bligh and Dyer (14) and resolved as described previously (6) . Phospholipid degradation of the control samples (no PLA 2 ) was ≤5%.
Assay of bacterial viability. To determine the effect of purified PLA 2 on bacterial viability, the colony-forming ability of the bacteria was measured before and after incubation with various doses of PLA 2 . Typical incubation mixtures contained 1-4 × 10 7 bacteria/ml in the desired medium (AF filtrate, TSB, used TSB, 70% pooled human serum [PHS] or RPMI-1640 [BioWhittaker Inc., Walkersville, Maryland, USA]) supplemented with 10 mM HEPES (pH 7.4; 20 mM for filtrate) and 1% (wt/vol) BSA (not added to serum samples). Calcium chloride (2 mM) was added to TSB, used TSB, and RPMI incubation mixtures. Incubations were carried out at 37°C for ≤ 3 h. Used TSB was prepared by centrifugation (11,000 g for 5 min) and sterile filtration (0.45 µm; Nalge Nunc International) of overnight bacterial cultures (grown in TSB) to remove bacteria and particulate matter. PHS was collected from blood of healthy human volunteers and prepared as described previously (15) . After incubation, aliquots of bacterial suspensions were serially diluted in sterile physiological saline and plated in 5 ml of molten (50°C) trypticase soy agar (Difco Laboratories). Bacterial viability was measured after 18-24 h of incubation at 37°C. When antibiotics were used, the bacteria were incubated with the desired antibiotic for 15 or 30 min at 37°C before the addition of PLA 2 . All antibiotics were
Figure 1
Stationary phase and starved S. aureus are less susceptible to PLA2-mediated killing and phospholipid degradation. [1-14 C]oleate-labeled S. aureus RN450 (10 7 /ml), harvested from midlogarithmic and stationary phase, were incubated in TSB supplemented with 1% BSA, 2 mM CaCl2, and 10 mM HEPES (pH 7.4) with or without 250 ng/ml of purified rabbit AF group IIA PLA2 at 37°C. At the indicated times, samples were removed to measure viability (a) and phospholipid degradation (b) as described in Methods. Alternatively, [1-14 C]oleate-labeled S. aureus RN450 (10 7 /ml) harvested from mid-logarithmic phase were incubated in fresh or used (nutrient-depleted) TSB supplemented with 1% BSA, 2 mM CaCl2 and 10 mM HEPES (pH 7.4) with and without 150 ng/ml of purified rabbit AF PLA2 at 37°C (c and d). At the indicated times, samples were removed to measure viability (c) and phospholipid degradation ( obtained from the Tisch Hospital Pharmacy. The sensitivity of RN450 to PLA 2 was comparable in all media used.
OD measurements. To monitor the growth or lysis of bacteria during the course of a viability assay, 500-µl aliquots of assay samples (4 × 10 7 bacteria/ml) were removed, placed in a microcuvette (Fisher Scientific Co., Pittsburgh, Pennsylvania, USA), and the OD measured at 550 nm on a Beckman DU-30 spectrophotometer.
Gram staining. Gram stains of bacterial samples with and without PLA 2 treatment were performed using the Bacto-3-Step Gram stain kit (Difco Laboratories) according to the manufacturer's directions.
Results
Stationary phase and starved S. aureus are less susceptible to PLA 2 . To determine whether bacterial populations with different growth rates differed in susceptibility to PLA 2 , S. aureus RN450 was harvested from mid-logarithmic and stationary phases; after resuspension at 10 7 /ml in TSB, it was tested for PLA 2 sensitivity. Under these experimental conditions, bacteria harvested from mid-logarithmic or stationary phase displayed different growth rates for an extended time (Fig. 1a) , providing an experimental setting in which the effects of growth differences on bacterial sensitivity to PLA 2 could be tested. Figure 1 (a and b) shows that purified rabbit group IIA PLA 2 produced more rapid and extensive degradation of the phospholipids of bacteria harvested from mid-logarithmic than from stationary phase. More dramatic differences in PLA 2 sensitivity were observed when bacteria harvested from mid-logarithmic phase and exposed to PLA 2 were compared in either fresh TSB or used TSB (Fig. 1, c  and d ). In the latter medium, the bacteria did not grow and were neither killed by PLA 2 nor suffered appreciable phospholipid degradation. PLA 2 activity toward autoclaved bacteria was the same in fresh and used TSB (data not shown), indicating that the inhibition of PLA 2 antibacterial action in used medium reflected an effect on the bacteria and not on the PLA 2 itself. Thus, these findings suggest that the growth state of the bacteria is an important determinant of bacterial sensitivity to PLA 2 .
A bacteriostatic antibiotic also reduces the susceptibility of S. aureus to PLA 2 . To further test this hypothesis, we examined the effect of a bacteriostatic antibiotic that promptly inhibits bacterial growth under conditions less likely to produce the broad metabolic effects that accompany bacterial starvation or the transition to stationary phase. For this purpose, we used a multi-drug-resistant clinical isolate of S. aureus (strain 18) that is growth inhibited, but not killed, by treatment with erythromycin. In the absence of erythromycin, this strain of S. aureus was highly susceptible to PLA 2 ; 50 ng/ml of this enzyme was sufficient to cause virtually quantitative degradation of membrane phospholipids within 30 minutes and >3 logs killing within 90 minutes (Fig. 2, a and b) . In contrast, pretreatment of strain 18 with erythromycin for 15 minutes before PLA 2 exposure greatly retarded the degradation of bacterial membrane phospholipids by PLA 2 and rendered the bacteria largely resistant to the bactericidal action of PLA 2 (Fig. 2, a and b) .
Erythromycin had no adverse effect on PLA 2 activity toward autoclaved bacteria (data not shown), indicating that erythromycin was not directly inhibiting the catalytic activity of PLA 2 . In addition, erythromycin did not inhibit the initial binding of PLA 2 to the bacteria (data not shown), an essential first step in the antibacterial action of mammalian group IIA PLA 2 (Liang, N.S., et al., manuscript in preparation). Thus, these results support the hypothesis that bacterial growth and cell division promote the susceptibility of S. aureus to PLA 2 -mediated killing, apparently by facilitating the access of PLA 2 to the phospholipids in the bacterial membrane. To further explore the possibility that the integrity of the cell wall is a major variable in the sensitivity of S. aureus to host PLA 2 , the effect on PLA 2 sensitivity of antibiotics that interfere with peptidoglycan synthesis was examined.
Ampicillin promotes PLA 2 action against S. aureus. The preceding findings suggested that cell-wall turnover associated with cell growth and division may promote the antibacterial action of PLA2. If this is correct, weakening of the cell-wall structure by antibiotics should also render the bacteria more susceptible to PLA 2 . To explore this possibility, S. aureus strain 18 was treated with ampicillin, erythromycin, or no antibiotic for 15 minutes before treatment with increasing concentrations of PLA 2 . As shown above, in a different medium, bacteria pretreated with erythromycin were more resistant to the antibacterial and phospholipolytic effects of PLA 2 at all concentrations tested (Fig. 3, a and b) . In contrast, bacteria pretreated with subinhibitory doses of ampicillin were more susceptible than the untreated bacteria to PLA 2 ( Fig. 3, a and b) . Thus, ampicillin pretreatment of S. aureus significantly increased bacterial susceptibility to PLA 2 -mediated phospholipid degradation at sublethal concentrations of PLA 2 (Fig. 3b) .
Antibacterial synergy between cell-wall active antibiotics and PLA 2 against E. faecium. Although pretreatment of S. aureus with subinhibitory doses of ampicillin appreciably increased the PLA 2 degradation of bacterial membrane phospholipids, effects on PLA 2 -triggered killing were only modest. Reasoning that bactericidal synergy might be more pronounced toward Gram-positive bacteria that are inherently more resistant to PLA 2 , we examined the effects of cell-wall active antibiotics on PLA 2 -triggered killing of two multi-drug-resistant clinical isolates of E. faecium.
As expected, treatment of these two strains with either β-lactam antibiotics or vancomycin alone had little or no effect on bacterial viability (Fig. 4, a-f ). However, with both strains, pretreatment with either ampicillin, cephalothin, or vancomycin increased bacterial killing produced when LD 50 doses of PLA 2 were added (Fig. 4,  a-f) . The effects of PLA 2 were synergistic with both β-lactams (Fig. 4, a, b, d , and e) and additive with vancomycin (Fig. 4, c and f) . These results indicate that PLA 2 and β-lac-
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The tam antibiotics act synergistically toward both multidrug-resistant S. aureus and E. faecium. Susceptibility of autolysis-deficient S. aureus to PLA 2 . Bacterial cell-wall-degrading enzymes (autolysins) play an important role in cell-wall morphogenesis that accompanies cell growth, division/separation, and peptidoglycan turnover (16, 17) . Thus, these enzymes could contribute to the greater sensitivity of growing bacteria to PLA 2 action by producing localized sites of weakened and thinned peptidoglycan (18, 19) . To test this hypothesis, we compared the sensitivity of S. aureus RN450 (lyt + ) and an isogenic, autolysis-deficient mutant (Lyt -) to PLA 2 .
In contrast to the effect of bacterial growth inhibition (Fig. 1, b and d; Fig. 2b; and Fig. 3b) , the reduced autolysin content of the lyt -RN450 mutant did not render these bacteria more resistant to the phospholipolytic action of PLA 2 . Thus, PLA 2 -triggered phospholipid degradation in RN450 (lyt + ) and Lyt -is essentially the same (Fig. 5a) . However, the lyt -strain is much less susceptible to killing by PLA 2 (Fig. 5b) , and, in contrast to the wild-type strain, is not lysed during PLA 2 treatment (Fig. 5c) . Gram stains confirmed the much greater lysis of the lyt + than of the lyt -strain (data not shown). We conclude that bacterial autolysins play a major role in PLA 2 -triggered killing and postkilling lysis of S. aureus.
Discussion
In this study, we have shown that the susceptibility of Gram-positive bacteria to the bactericidal action of mammalian group IIA PLA 2 is profoundly affected by the bacterial growth rate. Thus, conditions that affect cell-wall structure -cell growth, division, and separation, treatment with cell-wall active antibiotics, and the action of autolysins -all correlate with bacterial sensitivity to PLA 2 . S. aureus was less susceptible to the antibacterial actions of PLA 2 when bacterial growth was slowed by reaching stationary phase (Fig. 1, a and b) , by incubation in a nutrient-depleted medium (Fig. 1, c and d) , or by antibiotic-induced bacteriostasis (Fig. 2) . Conversely, susceptibility to PLA 2 was increased when cell-wall active antibiotics (Figs. 3 and 4) or endogenous autolysins weakened envelope structure (Fig. 5) .
Bacteria undergo multiple structural and physiological changes during the transition from a growing to a nongrowing state. Alterations include increased crosslinking and thickening of the peptidoglycan (16, 20) , decreased cell-wall turnover (21), transmembrane potential (22) , autolysis (9) , and changes in membrane phospholipid composition (23) and protein synthesis (24) . Many of these changes alter the susceptibility of the bacteria to antibacterial agents (20, 25, 26) . Therefore, under our experimental conditions the factor(s) responsible for the decreased sensitivity of the nongrowing bacteria cannot yet be defined precisely. However, the results of this study lead us to propose that the structure of the envelope peptidoglycan is a major determinant of the actions of PLA 2 against Gram-positive bacteria.
First, the transition from active bacterial growth to a nongrowing state is accompanied by increased O-acetylation and thickening of the peptidoglycan layer (16, 20) and a dramatic increase in resistance of S. aureus to the antibacterial actions of the enzyme, most likely because of reduced access to membrane phospholipids. In contrast, the autolytic activity associated with cell-wall biogenesis may account for the high sensitivity of growing bacteria to PLA 2 . Second, β-lactam antibiotics, which reduce the cross-linking of peptidoglycan, also promote the antibacterial action of PLA 2 .
However, the ability of the PLA 2 to reach and hydrolyze the bacterial phospholipids is not sufficient to kill the bacteria. The demonstration that PLA 2 -treated, autolysis-deficient S. aureus undergo as much phospholipolysis as their wild-type counterparts but largely escape killing and lysis (Fig. 5) indicates that the phospholipolytic and bactericidal actions of the PLA 2 need not be linked; and it implies that activation of autolytic events is also required for killing of S. aureus by PLA 2 . Because the lyt + and lyt -strains of S. aureus are equally susceptible to phospholipid degradation by PLA 2 , differences in their autolytic activity (9) pholipids further points to remarkable repair capabilities of the bacteria in the absence of autolytic activity. The activities of autolysins are tightly regulated (27) , both temporally and spatially, to permit the discrete action needed for cell-wall biogenesis (16, 18, 19) , without causing diffuse cell-wall alterations that would be harmful to the bacteria. Because the growth rates of the lyt + and lyt -strains are comparable, the actual level of autolytic activity coupled to cell growth processes may be similar in both strains, despite the large difference in overall autolytic activity.
Based on these observations, we propose a model for mammalian group IIA PLA 2 action against Gram-positive bacteria (outlined in Fig. 6 ). First, the PLA 2 must bind and penetrate the cell-wall, a feature that distinguishes this PLA 2 from other closely related, but nonbactericidal, PLA 2 's (ref. 6; and Liang, N.S., et al., manuscript in preparation). These initial interactions are dependent on electrostatic attraction between the very cationic group IIA PLA 2 and anionic bacterial envelope constituents. One bacterial envelope component that could be particularly important in this context is lipoteichoic acid (LTA), an abundant anionic membrane glycolipid that extends through the cell-wall to the outer surface. We speculate that the initial binding of PLA 2 to LTA on the outer surface of the bacteria is followed by penetration of the PLA 2 down the repeating glycerol phosphate chain of LTA permitting PLA 2 to reach the cell membrane. Binding of PLA 2 to LTA might also displace the less cationic autolysins, relieving this negative constraint on autolysin activity (28) and producing discrete cell-wall changes at sites of PLA 2 binding that further promote PLA 2 penetration. Penetration of PLA 2 may be favored at envelope sites with decreased crosslinking and/or increased active autolysins, e.g., sites of new cell-wall growth.
When the PLA 2 causes massive phospholipid degradation, thereby destabilizing the association of LTA with the cell membrane, a more diffuse activation of autolysins (in lyt + strains) may follow and, consequently, result in irreversible bacterial injury. The activities of cytosolic autolysins, which are controlled by close association with membrane phospholipids (29, 30) , may also be activated because of the membrane disruption caused by PLA 2 . The decreased autolysin content of the autolysis-deficient strain of S. aureus may explain why, in this situation, the bacteria are not lysed, but instead remain largely intact and able to repair the membrane damage caused by PLA 2 .
Intrinsic differences in cell-wall peptidoglycan cross-linking and/or autolytic activity among Gram-positive bacterial species may account for different sensitivities to PLA 2 (6) . For example, B. subtilis, which is exquisitely sensitive to PLA 2 , has high autolytic activity (31) , whereas less susceptible species display lower autolytic activity or possess fewer autolysins (32) . These differences could be linked to different growth patterns of the bacterial species. It has been speculated that B. subtilis may undergo random or diffuse cell-surface extension by the addition of new cell wall at many sites (33) , thereby creating more sites at which PLA 2 can cross the cell wall. Conversely, enterococcal species, which are much less sensitive to PLA 2 (6), exhibit patterns of zonal growth (34) , where new cell-wall material is inserted at a single region or zone, resulting in fewer sites for PLA 2 access to the membrane phospholipids.
The demonstration of synergism between sublethal doses of β-lactam antibiotics and low concentrations of PLA 2 against two drug-resistant enterococcal pathogens (Fig. 4 ) that differ in their intrinsic susceptibilities to PLA 2 not only further supports the contention that peptidoglycan structure is an important variable in the antibacterial actions of PLA 2 , but may also have broader biological implications. These findings suggest that even in antibiotic-resistant bacteria, discrete changes in the cell wall caused by subinhibitory doses of β-lactam antibiotics (35, 36) are sufficient to promote access of PLA 2 to the membrane phospholipids, setting in motion both their degradation and autolytic events resulting in killing.
In contrast to the synergistic effects of β-lactam antibiotics and PLA 2 , the combined effects of PLA 2 and vancomycin are additive. This difference is observed over a wide range of vancomycin concentrations, including doses at which β-lactam antibiotics and vancomycin, by themselves, have similar effects on bacterial growth and viability (data not shown). The finding that β-lactam antibiotics, which decrease peptidoglycan cross-linking, acted synergistically with PLA 2 , whereas combinations with vancomycin (an agent that inhibits cell-wall synthesis) were only additive, may again reflect an important role of the peptidoglycan structure in PLA 2 action.
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Figure 6
Model for PLA2 action against Gram-positive bacteria.
